title: Effects of interleukins on plasma arginine vasopressin and oxytocin levels in conscious, freely moving rats.
abstract: To elucidate whether interleukins are involved in vasopressin or oxytocin release during cytokine-related stressful conditions, we examined the effects of human interleukin-1 beta and interleukin-6 on plasma vasopressin and oxytocin levels in rats. Interleukin-1 beta administrated intravenously stimulated both the vasopressin and oxytocin secretion in dose-dependent manners. Neither hormone release was observed following interleukin-6 administration. Pretreatment with aspirin significantly attenuated the effects of interleukin-1 beta on both the vasopressin and oxytocin levels. SC-19220, a prostaglandin E2 receptor antagonist, did not affect the interleukin-1 beta-induced increase of plasma oxytocin levels, but almost completely abolished its effect on plasma vasopressin levels. These results suggest that under certain stressful conditions which accompany the stimulation of cytokine production, interleukin-1 is involved in the increase of plasma vasopressin and oxytocin levels and, moreover, different kinds of prostaglandins are suggested to participate in these interleukin-1-induced hormone release.
authors.affiliation: Division of Emergency Medicine and Critical Care Medicine, Kyoto University School of Medicine, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Naito
authors.forename: J
authors.initials: J
authors.lastname: Fukata
authors.forename: K
authors.initials: K
authors.lastname: Shindo
authors.forename: O
authors.initials: O
authors.lastname: Ebisui
authors.forename: N
authors.initials: N
authors.lastname: Murakami
authors.forename: T
authors.initials: T
authors.lastname: Tominaga
authors.forename: Y
authors.initials: Y
authors.lastname: Nakai
authors.forename: K
authors.initials: K
authors.lastname: Mori
authors.forename: N W
authors.initials: NW
authors.lastname: Kasting
authors.forename: H
authors.initials: H
authors.lastname: Imura
mesh_terms: D000818:Animals; D001127:Arginine Vasopressin / Q000097:blood*; D001241:Aspirin / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D012531:Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide / Q000494:pharmacology; D006801:Humans; D006827:Hydantoins / Q000494:pharmacology; D007375:Interleukin-1 / Q000494:pharmacology*; D015850:Interleukin-6 / Q000494:pharmacology*; D008297:Male; D010121:Oxytocin / Q000097:blood*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011994:Recombinant Proteins / Q000494:pharmacology; D012016:Reference Values
chemical_list: D006827:Hydantoins; D007375:Interleukin-1; D015850:Interleukin-6; D010975:Platelet Aggregation Inhibitors; D011994:Recombinant Proteins; D001127:Arginine Vasopressin; C058848:BW A868C; D012531:Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; D010121:Oxytocin; D001241:Aspirin